Pre-incubation of LAK cells with NKG2D blocking antibodies reversed the enhanced susceptibility of LNT-229 glioma cells to immune cell killing upon LNA 93 exposure, indicating that the observed effects are indeed mediated through a modulation of the NKG2D system. The gene discussed is KLRK1; the disease is central nervous system cancer.